帕金森病模型大鼠神经干细胞移植基础研究
|
摘要
帕金森病(Parkinson's disease,PD)是一种发生于中老年期的,缓慢进展的神经系统退行性疾病,主要病理改变为中脑黑质致密部(substantia nigrapars compacta,SNc)多巴胺(dopamine,DA)能神经元变性死亡,导致纹状体来自黑质的DA能神经末梢减少,从而引起震颤、肌肉僵直、运动迟缓与体位不稳等一系列综合病症(Lotharius and Brundin,2002)。PD是继阿尔茨海默病(Alzheimer's disease,AD)之后第二大常见的神经系统退行性疾病,随着人口平均寿命延长和老龄化出现,PD的发病率呈现明显的上升势头。药物治疗以及脑深部电极(deep-brain stimulation,DBS)埋藏治疗可在一定程度上缓解患者的症状,但都存在一些副作用,而且不能从根本上抑制脑内DA能神经元的持续性死亡。近年来神经干细胞(neural stem cells,NSCs)的研究为细胞替代疗法治疗PD提供了潜在的应用前景,通过移植神经干细胞不但可以来替代部分丢失的的DA能神经元的功能,而且可以通过移植具有分泌神经营养因子特性的细胞抑制DA能神经元的丢失,长期有效地改善患者的症状。
在本研究的第一部分,我们利用本实验室建立的胚胎大鼠NSCs的取材和培养方法,分离E14 SD大鼠胚胎前脑室下带区(subventricular zone,SVZ)神经组织,在含有多种神经营养因子的无血清培养基中悬浮培养,经传代后培养出大量NSCs标记分子——神经巢蛋白(neuro epithelial stem cell protein,Nestin)阳性克隆球团。经免疫组织化学方法检测,这些阳性细胞克隆球团经诱导分化后可以分化为神经元、星型胶质细胞和少突胶质细胞,此结果说明本实验取自E14 SD大鼠SVZ区域的细胞具有自我增殖和多潜能分化特性。为长期跟踪移植细胞在体内存活、生长、迁移及分化的过程,我们运用用携带有增强型绿色荧光蛋白(enhanced green fluorescent protein,EGFP)基因的重组腺相关病毒(rAAV_2-EGFP)在体外培养条件下感染NSCs,通过病毒在细胞内表达EGFP使细胞带有绿色荧光标记。实验中发现,被AAV_2-EGFP感染后的NSCs仍具有持续的分裂增殖能力。EGFP标记的NSCs体外诱导分化后,整个细胞从胞体到突起末梢都带有绿色荧光标记,较好显示出了细胞的完整形态,经测定,体外EGFP标记率为65%。在第一部分研究,我们成功建立了NSCs的分离、培养、鉴定和EGFP标记示踪的方法。
PD在动物中没有自发倾向,进行PD实验研究需要建立适当的动物模型(陈生弟,陈先文,2003)。建立稳定的能模拟人类PD病理学和行为学改变的动物模型,对PD的发病机制和治疗等方面的研究具有重要的意义。PD大鼠模型由于可直接观察行为学改变、经济和易于操作等原因,成为目前应用最广的研究模型。现在PD模型的制作方法较为成熟,常用的是6-羟基多巴胺(6-hydroxydopamine,6-OHDA)损毁模型。在第二部分实验中,我们采用了单点内侧前脑束(medialforebrain bundle,MFB)注射6-OHDA方法制备一侧黑质损毁PD动物模型。共制备模型105只SD大鼠(Sprague Dawley,SD)。建模4周后经阿朴吗啡(apomorphine,APO)诱发旋转,旋转7 r/min以上者为成功模型,共有57只,行为学检测造模成功率为54%。模型动物造模成功后分别在30,60和120天后再次进行行为学检测以跟踪动物的自我恢复可能性,统计结果显示与造模成功后的初次检测结果无显著性差异(P＞0.05),表明PD模型稳定,没有自我修复现象。对PD模型组动物中脑黑质酪氨酸羟化酶(tyrosion hydrozylase,TH)免疫组织化学检测发现,成功PD大鼠中脑黑质正常侧TH反应阳性神经元数量较多,胞体较大,突起明显;而6-OHDA损毁侧TH阳性神经元数量则明显减少,细胞丢失超过90%以上。120天后PD模型动物损伤侧神经元数量减少仍然在90%以上,从组织学上证明模型的稳定。我们对成功的PD模型大鼠和正常大鼠分别在黑质或纹状体移植rAAV_2-EGFP标记的NSCs,移植后30、60和120天进行行为学检测。结果表明,NSCs移植到PD大鼠黑质或者纹状体,随着移植细胞在宿主脑内存活时间的延长,动物的行为学症状得到显著改善(P＜0.05,P＜0.01)。
在NSCs移植疗法中,NSCs作为一种外源性物质能否在损伤的黑质区域存活或者迁移,能否向黑质特定DA能神经元分化是细胞移植治疗PD疗效的关键。在第三部分实验中我们研究了移植细胞的行为变化。在细胞移植后30、60和120天不同时期取脑进行连续切片,在移植后不同时间的脑片上我们均发现了大量EGFP标记的细胞,说明EGFP作为示踪记在细胞移植后仍然长期稳定表达,外源性的NSCs可以通过异体移植在宿主内长期存活。对各时间段有移植细胞标记的脑片进行免疫组化检测,结果显示移植的细胞可以分化为多种神经元,星形胶质细胞和少突胶质细胞。通过EGFP的示踪显示,移植细胞具有迁移现象并存在一定规律。移植到黑质的细胞随着时间的延长,在黑质区迁移的距离也越远,但总体上移植细胞是在受损的黑质区域内迁移,只有少量的细胞迁移到黑质区域以外。移植到纹状体的细胞呈条索状排列从移植位点向腹后内侧黑质部位进行较为广泛的长距离迁移,迁移具有明显的方向性并在黑质致密部可见散在移植细胞。实验结果提示移植的NSCs可以在体内存活并有迁移和分化能力,CNS损伤区微环境对移植细胞的迁移和分化具有一定诱导作用。
综上所述,我们得出以下结论:
1,从E14天胚胎大鼠SVZ分离出来的神经细胞群,能不断的更新和增殖,具有良好的可传代性,体外培养可以诱导分化为神经元,星形胶质细胞和少突胶质细胞等多种类型,具有自我增殖和多潜能分化的干细胞特性。利用rAAV_2-EGFP感染NSCs,可以使NSCs带有稳定绿色荧光标记,标记后NSCs仍具有增殖和分化特性。成功建立了胚胎大鼠NSCs的培养、鉴定和EGFP示踪标记方法。
2,单点MFB注射6-OHDA制备一侧黑质损毁PD动物模型,应用免疫组化和行为学检测证明模型制作成功、可靠并可以长期保持稳定。用体外培养的rAAV_2-EGFP标记的NSCs移植PD模型大鼠纹状体或者黑质,随着移植细胞在宿主脑内存活时间的延长,可以明显改善PD动物行为学症状。
3,跟踪NSCs移植后不同时间段移植细胞的分化和迁移特性。移植细胞在宿主脑内分化为多种神经元,星形胶质细胞和少突胶质细胞。移植细胞具有迁移现象并存在一定规律。移植到黑质的细胞总体上在受损的黑质区域内迁移;移植到纹状体的细胞呈条索状排列从移植位点向腹后内侧黑质部位进行较为广泛的长距离迁移,具有明显的方向性并在黑质致密部可见散在移植细胞。提示CNS损伤区微环境对移植细胞的迁移和分化具有一定诱导作用。
Parkinson's disease (PD) is a progressive neuro degenerative disease characterized by the loss of dopaminergic neurons in the substantia nigra pars compacta (SNc) and the consequent loss of projecting nerve fibers in the striatum produces the classical symptoms of resting tremor, bradykinesia, rigidity and postural instability etc. PD is one of the most common neuro degenerative disorders and has significantly the incidence of the upward trend with the extension of average life expectancy and population aging. Conventional pharmacological therapy and deep-brain stimulation (DBS) only temporarily reduce or alleviate the symptoms, but can not stop the process of dopaminergic neurons loss, long-term decline in efficacy, side effects increase. Neural stem cells (NSCs) provide attractive prospects for transplantation in neuro degenerative diseases. NSCs transplantation can not only complement the dopaminergic neurons loss, but also secrete neurotrophic factor to inhibit the loss process, long-term effective in improving symptoms of PD patients.
At the first part of the study, we use the ways of our laboratory set up to separate and cultivate the embryonic 14 d (E14) rats NSCs which were obtained from the forebrain subventricular zone (SVZ). The SVZ pieces were incubated in DMEM/F12 culture medium consisting of some neurotrophic factors without serum. The neurospheres were passaged weekly after dissociation and the cells were grown and expanded in flasks for several weeks. They demonstrated typical characteristics of stem cells including clonality, nestin-positivity and the ability to differentiate into any neural cell type in the CNS. The NSCs were labeled by enhanced green fluorescent protein (EGFP) using recombinant adeno-associated virus (rAAV_2) containing the marker gene of EGFP and still have a proliferation capacity after infection by AAV_2-EGFP. After differentiation, the EGFP labeled cells show a better morphological integrity from the cell body to neurite endings with a green fluorescent marker and in vitro the ratio of the cells with EGFP marker was about 65%. From this part, we successfully set up the method of isolation, culture, identification and marking tracer of NSCs.
PD without spontaneous tendency in animals, it is required to establish the appropriate animal models to carry out experimental study. A stable animal model PD with analog of human PD pathology and behavioral changes is of great significance to the study of pathogenesis and treatment. PD rat becomes the most widely used experimental research model because of its economic, easy to operate and the easy testing of its behavior change etc. The methods of PD model production are now more sophisticated and commonly made by 6-hydroxydopamine (6-OHDA) administrtion. At the second part of our study, the adult Sprague-Dawley(SD) rats were used to establish PD models by unilateral microinjection of 6-OHDA which damaged dopaminergic neurons in the substantia nigra. Stereotaxic injections of 6-OHDA were performed in the right MFB of 105 adult SD rats. After 4 weeks, 57 rats were selected as successful PD models based on the presence of apomorphine-induced rotational behavior (>7 rpm). The success rate for production of the 6-OHDA-induced PD model was 54%. The effects of the PD models' stability were evaluated during the first, second, and fourth months. There was no improvement in rotational scores in any PD rats at any time point(P >0.05). The extent of the 6-OHDA lesions in the MFB was verified by immunohistochemistry using an anti- tyrosion hydroxylase (TH) antibody. Brain sections from both (lesioned and unlesioned) sides of the SNc were compared simultaneously. The neurons are in larger quantities, larger cell body and obvious neurite in the non-lesioned area. A significant reduction more than 90% in TH-positivity compared with the non-lesioned area (left side) was seen in the lesioned area (right side). This phenomenon was also observed four months later and proved the model's success and stability. The NSCs labeled by EGFP were transplanted into the SNc or striatum of PD rats or normal rats. PD rats grafted with NSCs in the SNc or striatum showed significant reductions in rotational behavior compared with the pre-transplantation period with the grafed cells survival in the host (P <0.05, P<0.01).
With NSCs transplantation for the treatment of PD, the transplanted cells, whether or not to have the capacity of migration and anchoring at the injury site specifically or survival and differentiation to dopaminergic neurons in SN, are the key issues to the effect of the treatment of PD. At the third part of this study, we explored the behavior of cells after transplantation. The EGFP labeled cells are found in brain slices at any time point. EGFP tracer as recorded in the cells is long-term expression and exogenous NSCs can survive in host brain for long term. The immunohisto-chemistry results showed that grafted cells can differentiate into neurons, oligodendrocytes and glial cells in brain slices at any time point. There was regularity about the migration of grafted cells. The grafted cells in the SN migrate farther the distance with time lengthens, but the overall are at the SN region migration, only a small number of cells migrated to the region outside the SN. The cells transplanted into the striatum were cord-like arrangement from the transplant site to the ventral posterior medial SN part through a more extensive long-distance migration and there were some scattered grafted cells at SN. These results suggest that transplanted NSCs can survive well in vivo and possess the ability to migrate and differentiate, with a high degree of plasticity. The migration and differentiation patterns of transplanted NSCs may be partially regulated by the injured brain.
In summary, we have reached the following conclusions:
1. The cultured NSCs origin from SVZ of embryonic 14 d SD rats had the characteristics of proliferation and passage ability. They demonstrated typical characteristics of stem cells including clonality and the ability to differentiate into any neural cell type in the central nervous system (CNS) . The NSCs were successfully labeled by EGFP using rAAV_2 containing the marker gene of EGFP and still had a proliferation capacity after infection. Successfully established the methods of culture and identification of NSCs from SVZ of embryonic SD rats.
2. To establish PD models by unilateral microinjection of 6-OHDA at MFB which damaged dopaminergic neurons in the substantia nigra. The effectiveness of the 6-OHDA lesion was confirmed by apomorphine-induced rotational behavior and verified by immunohistochemistry. The results demonstrated that methods of making PD models were successful. The PD rats grafted with EGFP labeled NSCs in the SNc or striatum showed significant reductions in rotational behavior compared with the pre-transplantation period.
3. To observe the differentiation and migration characteristics of grafted NSCs, grafed cells were traced and detected at various time periods after transplantation. The grafted NSCs had the ability to differentiate into any neural cell type in the host brain and there was regularity in migration. The grafted cells in SN migrated farther the distance with time lengthens, but the overall were at the SN region. The grafted cells in striatum migrated through a more extensive long-distance to SN and there were some scattered grafted cells at SN. The results suggested that the lesion microenvironment in the adult brain may be one of the factors which improve the survival, differentiation and migration of grafted cells in CNS.
在本研究的第一部分,我们利用本实验室建立的胚胎大鼠NSCs的取材和培养方法,分离E14 SD大鼠胚胎前脑室下带区(subventricular zone,SVZ)神经组织,在含有多种神经营养因子的无血清培养基中悬浮培养,经传代后培养出大量NSCs标记分子——神经巢蛋白(neuro epithelial stem cell protein,Nestin)阳性克隆球团。经免疫组织化学方法检测,这些阳性细胞克隆球团经诱导分化后可以分化为神经元、星型胶质细胞和少突胶质细胞,此结果说明本实验取自E14 SD大鼠SVZ区域的细胞具有自我增殖和多潜能分化特性。为长期跟踪移植细胞在体内存活、生长、迁移及分化的过程,我们运用用携带有增强型绿色荧光蛋白(enhanced green fluorescent protein,EGFP)基因的重组腺相关病毒(rAAV_2-EGFP)在体外培养条件下感染NSCs,通过病毒在细胞内表达EGFP使细胞带有绿色荧光标记。实验中发现,被AAV_2-EGFP感染后的NSCs仍具有持续的分裂增殖能力。EGFP标记的NSCs体外诱导分化后,整个细胞从胞体到突起末梢都带有绿色荧光标记,较好显示出了细胞的完整形态,经测定,体外EGFP标记率为65%。在第一部分研究,我们成功建立了NSCs的分离、培养、鉴定和EGFP标记示踪的方法。
PD在动物中没有自发倾向,进行PD实验研究需要建立适当的动物模型(陈生弟,陈先文,2003)。建立稳定的能模拟人类PD病理学和行为学改变的动物模型,对PD的发病机制和治疗等方面的研究具有重要的意义。PD大鼠模型由于可直接观察行为学改变、经济和易于操作等原因,成为目前应用最广的研究模型。现在PD模型的制作方法较为成熟,常用的是6-羟基多巴胺(6-hydroxydopamine,6-OHDA)损毁模型。在第二部分实验中,我们采用了单点内侧前脑束(medialforebrain bundle,MFB)注射6-OHDA方法制备一侧黑质损毁PD动物模型。共制备模型105只SD大鼠(Sprague Dawley,SD)。建模4周后经阿朴吗啡(apomorphine,APO)诱发旋转,旋转7 r/min以上者为成功模型,共有57只,行为学检测造模成功率为54%。模型动物造模成功后分别在30,60和120天后再次进行行为学检测以跟踪动物的自我恢复可能性,统计结果显示与造模成功后的初次检测结果无显著性差异(P＞0.05),表明PD模型稳定,没有自我修复现象。对PD模型组动物中脑黑质酪氨酸羟化酶(tyrosion hydrozylase,TH)免疫组织化学检测发现,成功PD大鼠中脑黑质正常侧TH反应阳性神经元数量较多,胞体较大,突起明显;而6-OHDA损毁侧TH阳性神经元数量则明显减少,细胞丢失超过90%以上。120天后PD模型动物损伤侧神经元数量减少仍然在90%以上,从组织学上证明模型的稳定。我们对成功的PD模型大鼠和正常大鼠分别在黑质或纹状体移植rAAV_2-EGFP标记的NSCs,移植后30、60和120天进行行为学检测。结果表明,NSCs移植到PD大鼠黑质或者纹状体,随着移植细胞在宿主脑内存活时间的延长,动物的行为学症状得到显著改善(P＜0.05,P＜0.01)。
在NSCs移植疗法中,NSCs作为一种外源性物质能否在损伤的黑质区域存活或者迁移,能否向黑质特定DA能神经元分化是细胞移植治疗PD疗效的关键。在第三部分实验中我们研究了移植细胞的行为变化。在细胞移植后30、60和120天不同时期取脑进行连续切片,在移植后不同时间的脑片上我们均发现了大量EGFP标记的细胞,说明EGFP作为示踪记在细胞移植后仍然长期稳定表达,外源性的NSCs可以通过异体移植在宿主内长期存活。对各时间段有移植细胞标记的脑片进行免疫组化检测,结果显示移植的细胞可以分化为多种神经元,星形胶质细胞和少突胶质细胞。通过EGFP的示踪显示,移植细胞具有迁移现象并存在一定规律。移植到黑质的细胞随着时间的延长,在黑质区迁移的距离也越远,但总体上移植细胞是在受损的黑质区域内迁移,只有少量的细胞迁移到黑质区域以外。移植到纹状体的细胞呈条索状排列从移植位点向腹后内侧黑质部位进行较为广泛的长距离迁移,迁移具有明显的方向性并在黑质致密部可见散在移植细胞。实验结果提示移植的NSCs可以在体内存活并有迁移和分化能力,CNS损伤区微环境对移植细胞的迁移和分化具有一定诱导作用。
综上所述,我们得出以下结论:
1,从E14天胚胎大鼠SVZ分离出来的神经细胞群,能不断的更新和增殖,具有良好的可传代性,体外培养可以诱导分化为神经元,星形胶质细胞和少突胶质细胞等多种类型,具有自我增殖和多潜能分化的干细胞特性。利用rAAV_2-EGFP感染NSCs,可以使NSCs带有稳定绿色荧光标记,标记后NSCs仍具有增殖和分化特性。成功建立了胚胎大鼠NSCs的培养、鉴定和EGFP示踪标记方法。
2,单点MFB注射6-OHDA制备一侧黑质损毁PD动物模型,应用免疫组化和行为学检测证明模型制作成功、可靠并可以长期保持稳定。用体外培养的rAAV_2-EGFP标记的NSCs移植PD模型大鼠纹状体或者黑质,随着移植细胞在宿主脑内存活时间的延长,可以明显改善PD动物行为学症状。
3,跟踪NSCs移植后不同时间段移植细胞的分化和迁移特性。移植细胞在宿主脑内分化为多种神经元,星形胶质细胞和少突胶质细胞。移植细胞具有迁移现象并存在一定规律。移植到黑质的细胞总体上在受损的黑质区域内迁移;移植到纹状体的细胞呈条索状排列从移植位点向腹后内侧黑质部位进行较为广泛的长距离迁移,具有明显的方向性并在黑质致密部可见散在移植细胞。提示CNS损伤区微环境对移植细胞的迁移和分化具有一定诱导作用。
Parkinson's disease (PD) is a progressive neuro degenerative disease characterized by the loss of dopaminergic neurons in the substantia nigra pars compacta (SNc) and the consequent loss of projecting nerve fibers in the striatum produces the classical symptoms of resting tremor, bradykinesia, rigidity and postural instability etc. PD is one of the most common neuro degenerative disorders and has significantly the incidence of the upward trend with the extension of average life expectancy and population aging. Conventional pharmacological therapy and deep-brain stimulation (DBS) only temporarily reduce or alleviate the symptoms, but can not stop the process of dopaminergic neurons loss, long-term decline in efficacy, side effects increase. Neural stem cells (NSCs) provide attractive prospects for transplantation in neuro degenerative diseases. NSCs transplantation can not only complement the dopaminergic neurons loss, but also secrete neurotrophic factor to inhibit the loss process, long-term effective in improving symptoms of PD patients.
At the first part of the study, we use the ways of our laboratory set up to separate and cultivate the embryonic 14 d (E14) rats NSCs which were obtained from the forebrain subventricular zone (SVZ). The SVZ pieces were incubated in DMEM/F12 culture medium consisting of some neurotrophic factors without serum. The neurospheres were passaged weekly after dissociation and the cells were grown and expanded in flasks for several weeks. They demonstrated typical characteristics of stem cells including clonality, nestin-positivity and the ability to differentiate into any neural cell type in the CNS. The NSCs were labeled by enhanced green fluorescent protein (EGFP) using recombinant adeno-associated virus (rAAV_2) containing the marker gene of EGFP and still have a proliferation capacity after infection by AAV_2-EGFP. After differentiation, the EGFP labeled cells show a better morphological integrity from the cell body to neurite endings with a green fluorescent marker and in vitro the ratio of the cells with EGFP marker was about 65%. From this part, we successfully set up the method of isolation, culture, identification and marking tracer of NSCs.
PD without spontaneous tendency in animals, it is required to establish the appropriate animal models to carry out experimental study. A stable animal model PD with analog of human PD pathology and behavioral changes is of great significance to the study of pathogenesis and treatment. PD rat becomes the most widely used experimental research model because of its economic, easy to operate and the easy testing of its behavior change etc. The methods of PD model production are now more sophisticated and commonly made by 6-hydroxydopamine (6-OHDA) administrtion. At the second part of our study, the adult Sprague-Dawley(SD) rats were used to establish PD models by unilateral microinjection of 6-OHDA which damaged dopaminergic neurons in the substantia nigra. Stereotaxic injections of 6-OHDA were performed in the right MFB of 105 adult SD rats. After 4 weeks, 57 rats were selected as successful PD models based on the presence of apomorphine-induced rotational behavior (>7 rpm). The success rate for production of the 6-OHDA-induced PD model was 54%. The effects of the PD models' stability were evaluated during the first, second, and fourth months. There was no improvement in rotational scores in any PD rats at any time point(P >0.05). The extent of the 6-OHDA lesions in the MFB was verified by immunohistochemistry using an anti- tyrosion hydroxylase (TH) antibody. Brain sections from both (lesioned and unlesioned) sides of the SNc were compared simultaneously. The neurons are in larger quantities, larger cell body and obvious neurite in the non-lesioned area. A significant reduction more than 90% in TH-positivity compared with the non-lesioned area (left side) was seen in the lesioned area (right side). This phenomenon was also observed four months later and proved the model's success and stability. The NSCs labeled by EGFP were transplanted into the SNc or striatum of PD rats or normal rats. PD rats grafted with NSCs in the SNc or striatum showed significant reductions in rotational behavior compared with the pre-transplantation period with the grafed cells survival in the host (P <0.05, P<0.01).
With NSCs transplantation for the treatment of PD, the transplanted cells, whether or not to have the capacity of migration and anchoring at the injury site specifically or survival and differentiation to dopaminergic neurons in SN, are the key issues to the effect of the treatment of PD. At the third part of this study, we explored the behavior of cells after transplantation. The EGFP labeled cells are found in brain slices at any time point. EGFP tracer as recorded in the cells is long-term expression and exogenous NSCs can survive in host brain for long term. The immunohisto-chemistry results showed that grafted cells can differentiate into neurons, oligodendrocytes and glial cells in brain slices at any time point. There was regularity about the migration of grafted cells. The grafted cells in the SN migrate farther the distance with time lengthens, but the overall are at the SN region migration, only a small number of cells migrated to the region outside the SN. The cells transplanted into the striatum were cord-like arrangement from the transplant site to the ventral posterior medial SN part through a more extensive long-distance migration and there were some scattered grafted cells at SN. These results suggest that transplanted NSCs can survive well in vivo and possess the ability to migrate and differentiate, with a high degree of plasticity. The migration and differentiation patterns of transplanted NSCs may be partially regulated by the injured brain.
In summary, we have reached the following conclusions:
1. The cultured NSCs origin from SVZ of embryonic 14 d SD rats had the characteristics of proliferation and passage ability. They demonstrated typical characteristics of stem cells including clonality and the ability to differentiate into any neural cell type in the central nervous system (CNS) . The NSCs were successfully labeled by EGFP using rAAV_2 containing the marker gene of EGFP and still had a proliferation capacity after infection. Successfully established the methods of culture and identification of NSCs from SVZ of embryonic SD rats.
2. To establish PD models by unilateral microinjection of 6-OHDA at MFB which damaged dopaminergic neurons in the substantia nigra. The effectiveness of the 6-OHDA lesion was confirmed by apomorphine-induced rotational behavior and verified by immunohistochemistry. The results demonstrated that methods of making PD models were successful. The PD rats grafted with EGFP labeled NSCs in the SNc or striatum showed significant reductions in rotational behavior compared with the pre-transplantation period.
3. To observe the differentiation and migration characteristics of grafted NSCs, grafed cells were traced and detected at various time periods after transplantation. The grafted NSCs had the ability to differentiate into any neural cell type in the host brain and there was regularity in migration. The grafted cells in SN migrated farther the distance with time lengthens, but the overall were at the SN region. The grafted cells in striatum migrated through a more extensive long-distance to SN and there were some scattered grafted cells at SN. The results suggested that the lesion microenvironment in the adult brain may be one of the factors which improve the survival, differentiation and migration of grafted cells in CNS.
引文
[1]Gage FH,Mammalian neural stem cells,Science.2000 Feb 25;287(5457):1433-8.
[2]Maslov AY,Barone TA,Plunkett RJ,et al.Neural stem cell detection,characterization and age-related changes in the subventricular zone of mice.J.Neurosci.2004 Feb 18;24(7):1726-33.
[3]Johansson CB,Momma S,Clarke DL,et al.Identification of a neural stem cell in the adult mammalian central nervous system.Cell 1999 Jan 8;96(1):25-34.
[4]Anderson DJ,Michelsohn A.Role of glueocorticoids in the chromaffin neuron developmental decision.IntJ Dev Neurosci,1989,7(5):475-87.
[5]刘伟国.神经干细胞基因转导治疗中枢神经系统损伤的研究进展.现代实用医学,2008,8(20):581-583.
[6]Yue F,Chen B,Wu D,et al.Biological properties of neural progenitor cells isolated from the hippocampus of adult cynomolgus monkeys.Chin Med J(Engl),2006 Jan 20;119(2):110-6.
[7]Gobbel GT,Choi SJ,Beier S,et al.Long-term cultivation of multipotential neural stem cells from adult rat subependyma.Brain Res.2003 Aug 8;980(2):221-32.
[8]Galli R,Gritti A,Bonfanti L,et al.Neural Stem cells:an overview.Circ Res.2003 Apr 4;92(6):598-608.
[9]李凌松,路艳艳.神经干细胞以及帕金森病的细胞治疗.北京大学学报(医学版),2002,34(5):499-505
[10]Harrower TP,Tyers P,Hooks Y,et al.Long-term survivala nd integration of porcine expanded neural precursor cell grafts in a rat model of Parkinson's disease.Exp Neurol,2006;197(1):56-69.
[11]薛杉,张旺明.神经干细胞的迁移和网络化.中华神经医学杂志,2004,3(3)235-238.
[12]An YH,Wang HY,Gao ZX,et al.Differentiation of rat neural stem cells and its relationship with environment.Biomed Environ Sci.2004 Mar;17(1):1-7.
[13]Hayashi J,Takagi Y,Fukuda H,et al.Palmate embryonic stem cell-derived neuronal progenitors transplanted into ischemic brain.J Cereb Blood Flow Metab 2006 Jul;26(7):906-14.
[14]Zhang Z,Jiang Q,Jiang F,et al.In vivo magnetic resonance imaging tracks adult neural progenitor cell targeting of brain tumor.Neuroimage 2004 Sep;23(1):281-7.
[15]Wen T,Li H,Song H,et al.Down-regulation of specific Gene expression by double-strand RNA induces neural stem cell differentiation in vitro.Mol Cell Bioehem,2005 Jul;275(1-2):215-21.
[16]Imitola J,Comabella M,Chandraker AK,etal.Neural stem/progenitor cells express costimulatory molecules that are differentially regulated by inflammatory and apoptotie stimuli.Am J Pathol 2004 May;164(5):1615-25.
[17]Cai J,Limke TL,Ginis I,et al.Identifying and tracking neural stem cells.Blood Cells Mol Dis,2003;31(1):18-27.
[18]Sun L,Lee J,Fine HA.Neuronally expressed stem cell factor induces neural stem cell migration to areas of brain injury.J Clin Invest,2004 May;113(9):1364-74.
[19]Arvidsson A,Collin T,Kirik D,et al.Neuronal replacement from endogenous precursors in the adult brain after stroke.Nat Med,2002 Sep,8(9):963-70.
[20]Toda H,Takahashi J,Iwakami N,et al.Grafting neural stem cells improved the impaled spetial recognition in isehemie rats.Neurosci Lett,2001 Dec;316(1):9-12.
[21]Zhang ZG,Jiang Q,Zhang R,et al.Magnetic resonance imaging and neurosphere therapy of stroke in rat.Ann Neurol,2003,53(2):259-63.
[22]安沂华,王红云,张相彤,等.大鼠胚胎神经干细胞移植治疗脑出血的实验研究冲华神经外科杂志,002,18(1):50-53.
[23]薛村水,李光来,贺杰峰,等.大鼠及出血后神经干细胞移植的实验研究.中西医结合心脑血管病杂志,2004,2(5):283-285.
[24]Thored P,Arvidsson A,Cacci E,et al.Persistent production of neurons from adult brain stem cells during recovery after stroke.Stem Cells,2006,24(3):739-47.
[25]Watts RL,Raiser CD,Stover NP,et al.Stereotaxic intrastriatal implantation of retinal pigment epithelial cells attached to microcarriers in advanced Parkinson's disease patients.Neuro 2002;58(Suppl 3):A241.
[26]Parati EA,Bez A,Ponti D,et al.Neural stem cells biological features and therapeutic potential in Parkinson's disease.J Neurosurg Sci.2003 Mar;47(1):8-17.
[27]Akerud P,Canals JM,Snyder EY,et al.Neuroprotection through delivery of glial cell linedrived neurotrophic factor by neural stem cells in a mouse of Parkinson's disease.J Neurosci.2001 Oct 15;21(20):8108-18.
[28]Takagi Y,Takahashi J,Salki H,et al.Dopaminergic neurons generated from monkey embryonic stem cells function in a Parkinson primate model.J Clin Invest,2005,115(1):102-9.
[29]Redmond DE,Bjugstad KB,Teng YD,et al.Behavioral improvement in a palmate Parkinson's model is associated with multiple homeostatic effects of human neural stem cells.Proc Natl Acad Sci USA,2007 Jul 17;104(29):12175-80.
[30]田增民,刘爽,李士月,等.人神经干细胞临床移植治疗帕金森病.第二军医大学学报,2003,24(9):957-959.
[31]Mattson MP.Emerging neuroprotective strategies for Alzheirmer's disease:dietary restriction,telomerase activation,and stem cell therapy.Exp Gerontol.2000 Jul;35(4):489-502.
[32]Grigoryan GA,Gray JA,Rashid T,et al.Conditionally immortal neuroepithelial stem cell grafts restore spatial learning in rats with lesions at the source of cholinergic forebrain projections cholinergic forebrain projections Conditionally immortal neuroepithelial stem cell grafts restore spatial learning in rats with lesions at the source of cholinergic forebrain projections.Restor Neurol Neurosci 2000;17(4):1.
[33]Sugaya K,Alvarez A,Marutle A,et al.Stem cell strategies for Alzheimer's disease therapy.Panminerva Med,2006 Jun,48(2):87-96.
[34]Wang Q,Matsumoto Y,Shindo T,et al.Neural stem cells transplantation in cortex in a mouse model of Alzheimer's disease.J Med Invest,2006 Feb,53(1-2):61-9.
[35]吴树亮,金连弘,李竹英.阿尔茨海默病动物模型的建立及神经干细胞对阿尔茨海默病的治疗作用.中国临床康复,2004,(19):3734-3736.
[36]Keene CD,Sonnen JA,Swanson PD,et al.Neural transplantation in Huntington disease:longterm grafts in two patients.Neurology 2007 Jun 12;68(24):2093-8.
[37]McBride JL,Behrstock SP,Chen EY,et al.Human neural stem cell transplants improve motor function in a rat model of Huntington's disease.J Comp Neurol,2004 Jul 19;475(2):211-9.
[38]Lee ST,Park JE,Lee K,et al.Noninvasive method of immortalized neural stem-like cell transplantation in an experimental model of Huntington's disease.J Neurosci Methods 2006 Apr 15;152(1-2):250-4.
[39]Lee ST,Chu K,Park JE,et al.Intravenous administration of human neural stem cells induces functional recovery in Huntington's disease rat model.Neurosci Res 2005 Jul;52(3):243-9.
[40]Roberts TJ,Price J,Williams SC,et al.Preservation of striatal tissue and behavioral function after neural stem cell transplantation in a rat model of Huntington's disease.Neuroscience 2006; 139(4):1187-99.
[41]Vazey EM,Chen K,Hughes SM,et al.Transplanted adult neural progenitor cells survive,differentiate and reduce motor function impairment in a rodent model of Huntington's disease.Exp Neurol.2006 Jun;199(2):384-96.
[42]Johann V,Schiefer J,Sass C,et al.Time of transplantation and cell preparation determine neural stem cell survival in a mouse model of Huntington's disease.Exp Brain Res.2007 Mar;177(4):458-70.
[43]Bachoud-Levi AC,Gaura V,Brugieres P,et al.Effect of fetal neural transplants in patients with Huntington's disease 6 years after surgery:a long term follow up study.Lancet Neurol.2006Apr;5(4):303-9.
[44]Aboody KS,Brown A,Rainov NG,et al.Neural stem cells display extensive tropism for pathology in adult brain:evidence from intracranial glioma.Proc Natl Acad Sci U S A.2000 Nov 7;97(23):12846-51.
[45]Zhang Z,Jiang Q,Jiang F,et al.In vivo magnetic resonance imaging tracks adult neural progenitor cell targeting of brain tumor.Neuroimage 2004 Sep;23(1):281-7.
[46]Tang Y,Shah K,Messedi SM,et al.In vivo tracking of neural progenitor cell migration to glioblastomas.Hum Gene Ther.2003 Sep 1;14(13):1247-54.
[47]Ehtesham M,Kabos P,Kabosova A,et al.The use of intedeukin 12-secreting neural stem cells for the treatment of intracranial glioma.Cancer Res.2002 Oct 15;62(20):5657-63.
[48]Ke Y,Chi L,Xu R,et al.Early response of endogenous adult neural progenitor cells to acute spinal cord injury in mice.Stem Cells 2006 Apr;24(4):1011-9.
[49]Li J,Sun CR,Zhang H,et al.Induction of functional recovery by co-transplantation of neural stem cells and Schwann ceils in a rat spinal cord contusion injury model.Biomed Environ Sci,2007 Jun;20(3):242-9.
[50]Guo JS,Zeng YS,Li HB,et al.Cotransplant of neural stem cells and NT-3 gene modified Schwann cells promote the recovery of transected spinal cord injury.Spinal Cord,2007 Jan;45(1):15-24.
[51]Lu P,Jones LL,Snyder EY,et al.Neural stem cells constitutively secrete neurotrophic factors and promote extensive host axonal growth after spinal cord injury.Exp Neurol 2003 Jun;181(2):115-29.
[52]Kamei N,Tanaka N,Oishi Y,et al.BDNF,NT-3,and NGF released from transplanted neural progenitor cells promote corticospinal axon growth in organo typic cocultures.Spine,2007 May 20;32(12):1272-8.
[53]Conti L,Reitano E,Cattaneo E.Neural stem cell systems:diversities and properties after transplantation in animal models of diseases.Brain Pathol.2006 Apr;16(2):143-54.
[54]Kerr DA,Llado J,Shamblott MJ,et al.Human embryonic germ cell derivatives facilitate motor recovery of rats with diffuse motor neuron injury.J Neurosei 2003 Jun 15;23(12):5131-40.
[55]Wu P,Tarasenko YI,Gu Y,et al.Region-specific generation of cholinergic neurons from fetal human neural stem cells grafted in adult rat.Nat Neurosci,2002 Dec;5(12):1271-8.
[56]Halfpenny CA,Scolding NJ.Immune-modifying agents do not impair the survival,migration or proliferation of oligodendrocyte progenitors(CG-4) in vitro.J.Neuroimmunol,2003 Jun;139(1-2):9-16.
[57]Br(u|¨)stle O,Jones KN,Learish RD,et al.Embryonic stem cell-derived glial precursors:a source of myelinating transplants.Science,1999 Jul 30;285(5428):754-6.
[58]Pluchino S,Quattrini A,Brambilla E,et al.Injection of adult neurospheres induces recovery in a chronic model of multiple sclerosis.Nature,2003 Apr 17;422(6933):688-94.
[59]Buchet D,Serguera C,Zennon V,et al.Long-term expression of beta-glucoronidase by genetically modefied human neural progenitor cells graned into the mouse central nervous system.Mol Cell Neurosci 2002,19(3):389-401.
[60]Kim HJ,Sugimori M,Nakafuku M,et al.Control of neurogenesis and tyrosine hydroxylase expression in neural progenitor cells through bHLH proteins and Nurrl.Exp Neurol.2007 Feb;203(2):394-405.
[61]Andersson EK,Irvin DK,Ahlsi(o|¨) J,et al.Ngn2 and Nurrl act in synergy to induce midbrain dopaminergic neurons from expanded neural stem and progenitor cells.Exp Cell Res.2007 Apr 1;313(6):1172-80.
[62]Kim SU.Genetically engineered human neural stem cells for brain repair in neurological diseases.Brain Dev.2007 May;29(4):193-201.
[63]Mezey E,Nagy A,Szalayova I,et al.Comment on "Failure of bone marrow cells to transdifferentiate into neural cells in vivo".Science 2003 Feb 21;299(5610):1184.
[64]Deng J,Petersen BE,Steindler DA,et al.Mesenchymal stem cells spontaneously express neural proteins in culture and are neurogenic after transplantation.Stem Cells 2006 Apr;24(4):1054-64.
[65]Zhao LR,Duan WM,Reyes M,et al.Human bone marrow stem cells exhibit neural phenotypes and ameliorate neurological deficits after grafting into the ischemic brain of rats.Exp Neurol,2002 Mar;174(1):11-20.
[66]Nishio Y,Koda M,Kamada T,et al.The use of hemopoietic stem cells derived from human umbilical cord blood to promote restoration of spinal cord tissue and recovery of hindlimb function in adult rats.J Neurosurg Spine,2006 Nov;5(5):424-33.
[67]Garbuzova-Davis S,Willing AE,Zigova T,et al.Intravenous administration of human umbilical cord blood cells in amouse model of amyotrophic lateral sclerosis:distribution,migration,and differentiation.J Hematother Stem Cell Res,2003 Jun;12(3):255-70.
[68]Dasari VR,Spomar DG,Gondi CS,et al.Axonal remyelination bycord blood stem cells after spinal cord injury.J Neurotrauma,2007 Feb;24(2):391-410.
包新明,舒斯云.大鼠脑立体定位图谱,北京:人民卫生出版社,1991,30-59.
陈生弟,陈先文.帕金森病动物模型的研制,中国神经免疫学和神经病学杂志.2003,10(1):28-32.
陈生弟,徐德隆.实验性帕金森病动物模型的研究,上海医学,1987,10:120-121.
李凌松,路艳艳.神经干细胞以及帕金森病的细胞治疗,北京大学学报(医学版),2002,34(5):499-505.
曾水林,王磊,朱建宝等.帕金森病大鼠黑质区神经干细胞分化的观察,解剖与临床,2007,12(1):27-30.
Akerud P,Canals JM,Snyder EY,et al.Neuroprotection through delivery of glial cell linederived neurotrophic factor by neural stem cells in a mouse model of Parkinson's disease.J Neurosci.2001 Oct 15;21(20):8108-18.
Alvarez-Buylla A,Temple S.Stem cells in the developing and adult nervous system.J Neurobiol.1998 Aug;36(2):105-10.
Alvarez-Buylla A,Garcia-Verdugo JM & Tramontin AD.A unified hypothesis on the lineage of neural stem cells.Nat.Rev.Neurosci.2001,2,287-93.
Ankovic J.Parkinson's disease therapy:tailoring choices for early and late,young and old patients.Clin Neuropharmacol,2000,23(5):252-61.
Beal MF.Experimental model of Parkinson's disease.Nature Rev Neurosci,2001,2:325-34.
Belmadani A,Tran PB,Ren D,et al.The chemokine stromal cell-derived factor-1 regulates the migration of sensory neuron progenitors,J Neurosci,2005,25(16):3995-4003.
Belmadani A,Tran PB,Ren D,et al.Chemokines regulate the migration of neural progenitors to sites of neuroinflammation,J Neurosci,2006,26(12):3182-91.
Beltrami AP,Barlucchi L,Torella D,et al.Adult cardiacstem cells are multipotent and support myocardial regeneration.Cell,2003,114(6):763-76.
Ben-Hur T,Idelson M,Khaner H,et al.Transplantation of human embryonic stem cell-derived neural progenitors improves behavioral deficitin Parkinsonian rats,Stem Cells.2004;22(7):1246-55.
Beresford JM,Davenport AP,Sirinathsinghji DJ,et al.Experimental hemiparkinsonism in the rat following chronic unilateral infusion of MPP+ into the nigrostriatal dopamine pathway-Ⅱdifferential localization of dopamine and cholecystokinin receptors.Neurosci,1988,27(1): 129-43.
Betarbet R,Sherer TB,MacKenzie G,et al.Chronic systemic pesticide exposure reproduces features of Parkinson's disease.Nat Neurosci,2000,3:1301-06.
Blum D,Torch S,Lambeng N,et al.Molecular pathway involved in the neurotoxicity of 6-OHDA,dopamine and MPTP:contribution to the apoptotic theory in Parkinson s disease.Prog Neurobiol.2001 Oct;65(2):135-72.
Bj(o|¨)rklund A,Lindvall O.Cell replacement therapies for central nervous system disorders.Nat Neurosci.2000 Jun;3(6):537-44.
Bjugstad KB,Teng YD,Redmond DE Jr,et al.Human neural stem cells migrate along the nigrostriatal pathway in a primate model of Parkinson's disease.Exp Neurol.2008 Jun;211(2):362-9.
Brazel CY,Romanko MJ,Rothstein RP,et al.Roles of the mammalian subventricular zone in brain development.Prog Neurobiol.2003 Jan;69(1):49-69.
Brededau A,Correia AS,Anisimov SV,et al.Transplantation of human embryonic stem cellderived cells to a rat model of Parkinson's disease:effect of in vitro differentiation on graft survival and teratoma formation.Stem Cells.2006 Jun;24(6):1433-40.
Bronte-Stewart H.Parkinson's disease:Surgical options.Curr Treat Options Neurol,2003,5(2):131-47.
Brundin P,Isacson O,Bj(o|¨)rklund A.Monitoring of cell viability in suspensions of embryonic CNS tissue and its use as a criterion for intracerebral graft survival.Brain Res.1985 Apr 8;331(2):251-9.
Brundin P,Isacson O,Gage FH,et al.The 6-hydroxydopamine-lesioned mouse as a model for assessing functional effects of neuronal grafting.Brain Res.1986 Feb 26;366(1-2):346-9.
Chehab FF,Mounzih K,Lu R,et al.Early onset of reproductive function in normal female mice treated with leptin.Science,1997,275(5296):88-90.
Chmielnicki E,Benraiss A,Economides AN,et al.Adenovirally expressed noggin and brainderived neurotrophic factor cooperate to induce new medium spiny neurons from resident progenitor cells in the adult striatal ventricular zone.J Neurosci,2004,24(9):2133-42.
Cormack BP,Valdivia RH,Falkow S.FACS-optimized mutants of the green fluorescent protein (GFP).Gene,1996,173:33-8.
Cowan CA,Klimanskaya I,McMahon J,et al.Derivation of embryonic tem-cell lines from human blastocysts.N Engl J Med,2004,350:1353-56.
Cummings BJ,Uchida N,Tamaki SJ,et al.Human neural stem cells differentiate and promote locomotor recovery inspinal cord-injured mice.Proc Nail Acad Sci U S A.2005 Sep 27;102(39):14069-74.
Ding S,Messam CA,Li P,et al.Murine brain progenitor cells have the ability to differentiate into functional neurons and integrate into the CNS,Cell Transplant.,2006,15(8-9):699-710.
During MJ.Adeno-associated Virus as a gene delivery System.Adv Drug Deliv Rev.1997 Aug 11;27(1):83-94.
Dwain I,Xiangpeng Y,Zeng Z,et al.Neural stem cells-a promising potential therapy for brain tumors,Curr Stem Cell Res Ther.,2006,1(1):79-84.
Espino A,Liorens J,Calopa M,et al.Cerebrospinal dopamine metabolites in rats after intrastriatal administration of 6-hydroxydopamine or 1-methyl-4-phenylpyridinium ion.Brain Res.1995 Jan 9;669(1):19-25.
Feany MB,Bender WW.A drosophila model of Parkinson's disease.Nature,2000;404(6776):394-8.
Fillmore HL,Holloway KL,Gillies GT.Cell replacement efforts to repair neuronal injury:a potential paradigm for the treatment of Parkinson's disease.Review Neuro Rehabilitation,2005,20(3):233-42.
Gage FH,Ray J,Fisher LJ.Isolation,characterization,and use of stem cells from the CNS.Annu Rev Neurosci.1995;18:159-92.
Gage FH.Mammalian neural stem cells.Science.2000 Feb 25;287(5457):1433-8
Giasson BI,Duda JE,Quinn SM,et al.Neuronal alpha-synucleinopathy with severe movement disorder in mice expressing A53T human alphasynuclein.Neuron,2002;34(4):521-33.
Goldman SA,Roy NS,Beal MF,et al.Large stem cell grafts could lead to erroneous interpretations of behavioral results ? Nat Med.2007 Feb;13(2):118-9.
Hauser RA,Freeman TB,Snow BJ,et al.Long-term evaluation of bilateral fetal nigral transplantation in Parkinson's disease.Arch Neurol.1999 Feb;56(2):179-87.
Heim R,Cubitt AB,Heim RA,et al.Improved green fluorescence.Nature,1995,373(6516):663- 64.
Hellmann MA,Panet H,Barhum Y,et al.Increased survival and migration of engrafted mesenchymal bone marrow stem cells in 6-hydroxydopamine-lesioned rodents.Neurosci Lett. 2006 Mar 6;395(2):124-8.
Hockfield S,McKay RD.Identification of major cell classes in the developing mammalian nervous system.J.Neurosci.1985 Dec;5(12):3310-28.
Hori J,Ng TF,Shatos M,et al.Neural progenitor cells lack immuno-genicity and resist destruction as allografts.Stem Cells,2003,21(4):405-16.
Hudson JL,Levin DR,Hoffer BJ.A 16-channel automated romometer system for reliable measurement of turning behavior in 6-hydroxydopamine lesioned and transplanted rats.Cell Transplant.1993 Nov-Dec;2(6):507-14.
Hudson JL,Van Horne CG,Stromberg I,et al.Correlation of apomorphine and amphetamineinduced turning with nigrostfiatal dopamine content in unilateral 6-hydroxydopamine lesioned rats.Brain Res,1993,626:167-74.
Imitola J,Raddassi K,Park KI,et al.Directed migration of neural stem cells to sites of CNS injury by the stromal cell-derived factor lalpha/CXC chemokine receptor 4 pathway,Proc Natl Acad Sci U S A.2004 Dec 28;101(52):18117-22.
Isacson O,Costantini L,Schumacher JM,et al.Cell implantation therapies for Parkinson's disease using neural stem,transgenic or xengeneicdonor cells,Parkinsonism Relat Disord.2001Jul;7(3):205-12.
Iwanami A,Kaneko S,Nakamura M,et al.Transplantation of human neural stem cells for spinal cord injury in primates.J Neurosci Res.2005 Apr 15;80(2):182-90.
Jain M,Armstrong RJ,Elneil S,et al.Transplanted human neural precursor cells migrate widely but show no lesion-specific tropism in the 6-hydroxydopamine rat model of Parkinson's disease,Cell Transplant.,2006,15(7):579-93.
Jenner P.Pharmacology of dopamine agonists in the treatment of Parkinson's disease.Neurology 2002 Feb 26;58(4 Suppl 1):S1-8.
Ji JF,He BP,Dheen ST,et al.Expression of chemokine receptors CXCR4,CCR2,CCR5 and CX3CR1 in neural progenitor cells isolated from the subventricular zone of the adult rat brain,Neurosci Lett,2004 Jan 30;355(3):236-40.
Johe KK,Hazel TG,Muller T et al.Single factors direct the differentiation of stem cells from the fetal and adult central nervous system.Genes Dev.1996 Dec 15;10(24):3129-40.
Kawaguchi A,Miyata T,Sawamoto K,et al.Nestin-EGFP transgenie mice:visualization of the self-renewal and multipotency of CNS stem cells.Mol Cell Neurosci 2001 Feb,17(2):259-73.
Kelly S,Bliss TM,Shah AK,et al.Transplanted human fetal neural stem cells survive,migrate,and differentiate in ischemic rat cerebral cortex.Proc Natl Acad Sci U S A.2004 Aug 10;101(32):11839-44.
Kempermann G.Adult neurogenesis.2006,New York,NY:Oxford University Press.
Keyoung HM,Roy NS,Benraiss A,et al.High-yield selection and extraction of two promoterdefined phenotypes of neural stem cells from the fetal human brain.Nat Biotechnol.2001 Sep;19(9):843-50.
Kim JH,Auerbach JM,Rodriguez-Gomez JA,et al.Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson's disease,Nature.2002 Jul 4;418(6893):50-6.
Kim JY,Koh HC,Lee JY,et al.Dopaminergic neuronal differentiation from rat embryonic neural precursors by Nurrl overexpression.J Neurochem.2003 Jun;85(6):1443-54.
Lendahl U,Zimmerman LB,McKay RD.CNS stem cells express a new class of intermediate filament protein.Cell,1990,60,585-95.
Lindvall O,Kokaia Z,Martinez-Serrano A.Stem cell therapy for human neurodegenerative disorders-how to make it work.Nat Med.2004 Jul;10 Suppl:S42-50.
Lotharius J,Brundin P.Pathogenesis of Parkinson's disease:dopamine,vesicles and alphasynuclein.Nat Rev Neurosci.2002 Dec;3(12):932-42.
Lu M,Grove EA,Miller RJ.Abnormal development of the hippocampal dentate gyrus in mice lacking the CXCR4 chemokine receptor,Proc Natl Acad Sci USA,2002 May 14;99(10):7090-5.
Lundberg C,Martinez-Serrano A,Cattaneo E,et al.Survival,integration,and differentiation of neural stem cell lines after transplantation to the adult rat striatum.Exp Neurol.1997 Jun;145(2Pt 1):342-60.
Maitra A,Arking DE,Shivapurkar N,et al.Genomic alterations in cultured human embryonic stem cells.Nat Genet,2005 Oct;37(10):1099-103.
McBride JL,Behrstock SP,Chen EY,et al.Human neural stem cell transplants improve motor function in a rat model of Huntington's disease.J Comp Neurol.2004 Jul 19;475(2):211-9.
McCown TJ,Xiao X,Li J,et al.Differential and persistent expression patterns of CNS gene transfer by an adeno-associated virus(AAV) vector.Brain Res.1996 Mar 25;713(1-2):99-107.
McDonald JW,Liu XZ,Qu Y,et al.Transplanted embryonic stem cells survive,differentiate and promote recovery in injured rat spinal cord.Nat Med.1999 Dec;5(12):1410-2.
Mckay R.Stem cells in the central neurons system.Science,1997,276,66-71.
Meissner KK,Kirkham DL,Doering LC.Transplants of neurosphere cell suspensions from aged mice are functional in the mouse model of Parkinson's,Brain Res.2005 Sep 28;1057(1-2):105-12.
Menendez P,Bueno C,Wang L.Human embryonic stem cells:a journey beyond cell replacement therapies.Cytotherapy 2006;8(6):530-41.
Mogi M,Nagatsu T.Neurotrophins and cytokines in Parkinson's disease.Adv Neurol 1999;80:135-9.
Morizane A,Li JY,Brundin P.From bench to bed:the potential of stem cells for the treatment of Parkinson's disease.Cell Tissue Res.2008 Jan;331(1):323-36.
Mukhida K,Baghbaderani BA,Hong M,et al.Survival,differentiation,and migration of bioreactor-expanded human neural precursor cells in a model of Parkinson disease in rats,Neurosurg Focus,2008,24(3-4):E8.
M(u|¨)ller FJ,Snyder EY,Loring JF.Gene therapy:can neural stem cells deliver? Nat Rev Neurosci.2006 Jan;7(1):75-84.
Nakamura S,Takeda Y,Kanno M,et al.Application of bromodeoxyuridine(BrdU) and anti-BrdU monoclonal anti-body for the in vivo analysis of proliferative characteristics of human leukemia cells in bone marrow.Oncology,1991,48(4):285-9.
Newman MB,Bakay RA.Therapeutic Potentials of Human Embryonic Stem Cells in Parkinson's Disease.Neurotherapeutics 2008 Apr;5(2):237-51.
Nishino H,Hida H,Takei N,et al.Mesencephalic neural stem cells develop to dopamlmeergic neuronsmore strongly in dopamine- depleted striatum than in intact striatum.Exp Neurol,2000,164(1):209-14.
Nunes MC,Roy NS,Keyoung HM,et al.Identification and isolation of multipotential neural progenitor cells from the subcortical white matter of the adult human brain,Nat Med.2003 Apr;9(4):439-47.
Okano H,Kawahara H,Toriya M,et al.Function of RNA binding protein Musashi-1 in stem cells.Exp.Exp Cell Res.2005 Jun 10;306(2):349-56.
Okano H.Neuralstem cells:progression of basic research and perspective for clinical application.Keio J Med.2002 Sep;51(3):115-28.
Okano H,Sawamoto K.Neural stem cells:involvement in adult neurogenesis and CNS repair.Philos Trans R Soc Lond B Biol Sci.2008 Jun 27;363(1500):2111-22.
Okano H.Stem cell biology of the central nervous system,J Neurosci Res.2002 Sep 15;69(6):698-707.
Pahwa R,Factor SA,Lyons KE,et al.Practice parameter:treatment of Parkinson disease with motor fluctuations and dyskinesia(anevidence-basedreview):report of the Quality Standards Subcommittee of the American Academy of Neurology.Neurology,2006 Apr 11;66(7):983-95.
Park KI,Hack MA,Ourednik J,et al.Acute injury directs the migration,proliferation,and differentiation of solid organ stem cells:evidence from the effect of hypoxia-ischemia in the CNS on clonal "reporter" neural stem cells.Exp Neurol.2006 May;199(1):156-78.
Park KI,Liu S,Flax JD,et al.Transplantation of neural progenitor and stem-like cells:developmental insights may suggest new therapies for spinal cord and other CNS dysfunction.J.Neurotraumal,1999,6:675-687.
Paterna JC,B(u|¨)eler H.Recombinant adeno-associated virus vector design and gene expression in the mammalian brain.Methods.2002 Oct;28(2):208-18.
Pendleton RG,Parvez F,Sayed M,et al.Effects of pharmacological agents upon a transgenic model of Parkinson's disease in Drosophila melanogaster.J Pharmacol Exp Ther,2002 Jan;300(1):91-6.
Perlow MJ,Freed WJ,Hoffer BJ,et al.Brain grafts reduce motor abnormalities produced by destruction of nigrostriatal dopamine system.Science.1979 May 11;204(4393):643-7
Pevny LH,Sockanathan S,Placzek M et al.A role for SOX1 in neural determination.Development,1998 May;125(10),1967-78.
Prasher DC,Eckenrode VK,Ward WW,et al.Primary structure of theaequorea Victoria greenfluorescent protein.Gene,1992,111(2):229-33.
Reynolds BA,Tetzlaff W,Weiss S.A multipotent EGF-responsive striated embryonic progenitor cell produces neurons and astrocytes.J.Neurosci 1992 Nov,12(11),4565-74.
Reynolds BA,Weiss S.Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system.Science,1992 Mar 27;255(5052):1707-10.
Ramony Cajal S.1928 Degeneration and regeneration of the Nervous system.Oxford,UK:Oxford University Press.[Transl.by R.M.Day from the 1913 Spanish edn.]
Rietze RL,Valcanis H,Brooker GF,et al.Purification of a pluripotent neural stem cell from the adult mouse brain.Nature 2001 Aug 16;412(6848):736-9.
Ronald Mckay.Stem cells in the central neurous system.Science 1997 Apr 4;276(5309):66-71.
Sakakibara S,Imal T,Hamaguchi K,et al.Mouse-Musashi-1,a neural RNA-binding protein highly enriched in the mammalian CNS stemcell.Dev Biol.1996 Jun 15;176(2):230-42.
Samii A,Nutt JG,Ransom BR.Parkinson's disease.Lancet,2004 May 29,363(9423):1783-93.
Sipkis IG.A possible mechanism for the dopamine evoked synergistic disinhition of thalamic neurons via the direct and indirect pathways in the basal ganglin,Neurosie Behaiphysiol,2002,32(3):205.
Svendsen CN,Caldwell MA,Ostenfeld T.Human neural stem cells:isolation,expansion and transplantation,Brain Pathol.1999 Jul;9(3):499-513.
Takeuchi H,Natsume A,Wakabayashi T,et al.Intravenously transplanted human neural stem cells migrate to the injured spinal cord in adult mice in an SDF-1- and HGF-dependent manner,Neurosci Lett.,2007,426(2):69-74
Tan AK.Current and emerging treatment in Parkinson's disease.Ann Acad Med(singapore),2001,30(2):128-133.
Tang J,Xu HW,Fan XT,et al.Targeted migration and differentiation of engrafted neural precursor cells in amyloid beta-treated hippocampus in rats.Neurosci Bull 2007 Sep;23(5):263-70.
Tanja Z,V Pencea,R Betarbet,et al.Neuronal progenitor cells of the neonatal subventricular zone differentiate and disperse following transplantation into the adult rat striatum,Cell Transplantation,1998,7(2):137-156.
Thiruchelvam M,Richfield EK,Baggs RB,et al.The nigrostriatal dopaminergic system as a preferential target of repeated exposures to combined paraquat and maneb:implications for Parkinson's disease.J Neurosci,2000 Dec 15,20(24):9207-14.
Timmer M,Grosskreutz J,Schlesinger F,et al.Dopaminergic properties and function after grafting of attached neural precursor cultures.Neurobiol Dis.2006 Mar;21(3):587-606.
Tran PB,Ren D,Veldhouse TJ,et al.Chemokine receptors are expressed widely by embryonic and adult neural progenitor cells,J Neurosci Res 2004 Apr 1;76(1):20-34.
Turner DA,Kearney W.Scientific and ethical concerns in neural fetal Tissue transplantation,Neurosurgery 1993 Dec;33(6):1031-7.
Uchida N,Buck DW,He D,et al.Direct isolation of human central nervous system stem cells.Proc Natl Acad Sci U S A.2000 Dec 19;97(26):14720-5.
Ungerstedt D.6-hydroxydopamine induced degeneration of central monoamine neurons.Eur J Pharmocol,1988,5:107.
Vander Kooy D,Weiss S.Why stem cells? Science.2000 Feb 25;287(5457):1439-41.
Van Kampen JM,McGeer EG.Stoessl AJ.Dopamine transporter function assessed by antisense knockdown in the rat:protection from dopamine neurotoxicity.Synapse.2000 Sep 1;37(3):171-8.
Wang X,Lu Y,Zhang H,et al.Distinct efficacy of pre-differentiated versus intact fetal mesencephalon-derived human neural progenitor cells in alleviating rat model of Parkinson's disease.Int.J.Dev.Neurosci.2004 Jun,22(4):175-83.
Weiss S,Reynolds BA,Vescovi AL,et al.Is there a neural stem cell in the mammalian forebrain?TINS,1996,19(9):387-93.
Whitton PS.Inflammation as a causativefactor in theaetiology of Parkinson's disease.Br J Pharmacol 2007;150:963-76.
Wood HB,Episkopou V.Comparative expression of the mouse Sox1,Sox2 and Sox3 genes from pregastrulation to early somite stages.Mech Dev.1999 Aug;86(1-2):197-201.
Yasuhara T,Matsukawa N,Hara K,Yu G,Xu L,Maki M,Kim SU,Borlongan CV.Transplantation of human neural stem cells exerts neuroprotection in a rat model of Parkinson's disease.J Neurosci.2006 Nov 29;26(48):12497-511.
Zetterstroem T,Brundin P,Gage FH,et al.In vivo measurement of spontaneous release and metabolism of dopamine from intrastriatal nigral grafts using intracerebral dialysis.Brain Res.1986 Jan 8;362(2):344-9.
Zhang RL,Zhang L,Zhang ZG,et al.Migration and differentiation of adult rat subventricular zone progenitor cells transplanted into the adult rat striatum,Neuroscience.2003;116(2):373-82.
Zhou C,Wen ZX,Wang ZP,et al.Green fluorescent protein-labeled mapping of neural stem cells migrating towards damaged areas in the adult central nervous system.Cell Biol Int.2003;27(11):943-5.
[2]Maslov AY,Barone TA,Plunkett RJ,et al.Neural stem cell detection,characterization and age-related changes in the subventricular zone of mice.J.Neurosci.2004 Feb 18;24(7):1726-33.
[3]Johansson CB,Momma S,Clarke DL,et al.Identification of a neural stem cell in the adult mammalian central nervous system.Cell 1999 Jan 8;96(1):25-34.
[4]Anderson DJ,Michelsohn A.Role of glueocorticoids in the chromaffin neuron developmental decision.IntJ Dev Neurosci,1989,7(5):475-87.
[5]刘伟国.神经干细胞基因转导治疗中枢神经系统损伤的研究进展.现代实用医学,2008,8(20):581-583.
[6]Yue F,Chen B,Wu D,et al.Biological properties of neural progenitor cells isolated from the hippocampus of adult cynomolgus monkeys.Chin Med J(Engl),2006 Jan 20;119(2):110-6.
[7]Gobbel GT,Choi SJ,Beier S,et al.Long-term cultivation of multipotential neural stem cells from adult rat subependyma.Brain Res.2003 Aug 8;980(2):221-32.
[8]Galli R,Gritti A,Bonfanti L,et al.Neural Stem cells:an overview.Circ Res.2003 Apr 4;92(6):598-608.
[9]李凌松,路艳艳.神经干细胞以及帕金森病的细胞治疗.北京大学学报(医学版),2002,34(5):499-505
[10]Harrower TP,Tyers P,Hooks Y,et al.Long-term survivala nd integration of porcine expanded neural precursor cell grafts in a rat model of Parkinson's disease.Exp Neurol,2006;197(1):56-69.
[11]薛杉,张旺明.神经干细胞的迁移和网络化.中华神经医学杂志,2004,3(3)235-238.
[12]An YH,Wang HY,Gao ZX,et al.Differentiation of rat neural stem cells and its relationship with environment.Biomed Environ Sci.2004 Mar;17(1):1-7.
[13]Hayashi J,Takagi Y,Fukuda H,et al.Palmate embryonic stem cell-derived neuronal progenitors transplanted into ischemic brain.J Cereb Blood Flow Metab 2006 Jul;26(7):906-14.
[14]Zhang Z,Jiang Q,Jiang F,et al.In vivo magnetic resonance imaging tracks adult neural progenitor cell targeting of brain tumor.Neuroimage 2004 Sep;23(1):281-7.
[15]Wen T,Li H,Song H,et al.Down-regulation of specific Gene expression by double-strand RNA induces neural stem cell differentiation in vitro.Mol Cell Bioehem,2005 Jul;275(1-2):215-21.
[16]Imitola J,Comabella M,Chandraker AK,etal.Neural stem/progenitor cells express costimulatory molecules that are differentially regulated by inflammatory and apoptotie stimuli.Am J Pathol 2004 May;164(5):1615-25.
[17]Cai J,Limke TL,Ginis I,et al.Identifying and tracking neural stem cells.Blood Cells Mol Dis,2003;31(1):18-27.
[18]Sun L,Lee J,Fine HA.Neuronally expressed stem cell factor induces neural stem cell migration to areas of brain injury.J Clin Invest,2004 May;113(9):1364-74.
[19]Arvidsson A,Collin T,Kirik D,et al.Neuronal replacement from endogenous precursors in the adult brain after stroke.Nat Med,2002 Sep,8(9):963-70.
[20]Toda H,Takahashi J,Iwakami N,et al.Grafting neural stem cells improved the impaled spetial recognition in isehemie rats.Neurosci Lett,2001 Dec;316(1):9-12.
[21]Zhang ZG,Jiang Q,Zhang R,et al.Magnetic resonance imaging and neurosphere therapy of stroke in rat.Ann Neurol,2003,53(2):259-63.
[22]安沂华,王红云,张相彤,等.大鼠胚胎神经干细胞移植治疗脑出血的实验研究冲华神经外科杂志,002,18(1):50-53.
[23]薛村水,李光来,贺杰峰,等.大鼠及出血后神经干细胞移植的实验研究.中西医结合心脑血管病杂志,2004,2(5):283-285.
[24]Thored P,Arvidsson A,Cacci E,et al.Persistent production of neurons from adult brain stem cells during recovery after stroke.Stem Cells,2006,24(3):739-47.
[25]Watts RL,Raiser CD,Stover NP,et al.Stereotaxic intrastriatal implantation of retinal pigment epithelial cells attached to microcarriers in advanced Parkinson's disease patients.Neuro 2002;58(Suppl 3):A241.
[26]Parati EA,Bez A,Ponti D,et al.Neural stem cells biological features and therapeutic potential in Parkinson's disease.J Neurosurg Sci.2003 Mar;47(1):8-17.
[27]Akerud P,Canals JM,Snyder EY,et al.Neuroprotection through delivery of glial cell linedrived neurotrophic factor by neural stem cells in a mouse of Parkinson's disease.J Neurosci.2001 Oct 15;21(20):8108-18.
[28]Takagi Y,Takahashi J,Salki H,et al.Dopaminergic neurons generated from monkey embryonic stem cells function in a Parkinson primate model.J Clin Invest,2005,115(1):102-9.
[29]Redmond DE,Bjugstad KB,Teng YD,et al.Behavioral improvement in a palmate Parkinson's model is associated with multiple homeostatic effects of human neural stem cells.Proc Natl Acad Sci USA,2007 Jul 17;104(29):12175-80.
[30]田增民,刘爽,李士月,等.人神经干细胞临床移植治疗帕金森病.第二军医大学学报,2003,24(9):957-959.
[31]Mattson MP.Emerging neuroprotective strategies for Alzheirmer's disease:dietary restriction,telomerase activation,and stem cell therapy.Exp Gerontol.2000 Jul;35(4):489-502.
[32]Grigoryan GA,Gray JA,Rashid T,et al.Conditionally immortal neuroepithelial stem cell grafts restore spatial learning in rats with lesions at the source of cholinergic forebrain projections cholinergic forebrain projections Conditionally immortal neuroepithelial stem cell grafts restore spatial learning in rats with lesions at the source of cholinergic forebrain projections.Restor Neurol Neurosci 2000;17(4):1.
[33]Sugaya K,Alvarez A,Marutle A,et al.Stem cell strategies for Alzheimer's disease therapy.Panminerva Med,2006 Jun,48(2):87-96.
[34]Wang Q,Matsumoto Y,Shindo T,et al.Neural stem cells transplantation in cortex in a mouse model of Alzheimer's disease.J Med Invest,2006 Feb,53(1-2):61-9.
[35]吴树亮,金连弘,李竹英.阿尔茨海默病动物模型的建立及神经干细胞对阿尔茨海默病的治疗作用.中国临床康复,2004,(19):3734-3736.
[36]Keene CD,Sonnen JA,Swanson PD,et al.Neural transplantation in Huntington disease:longterm grafts in two patients.Neurology 2007 Jun 12;68(24):2093-8.
[37]McBride JL,Behrstock SP,Chen EY,et al.Human neural stem cell transplants improve motor function in a rat model of Huntington's disease.J Comp Neurol,2004 Jul 19;475(2):211-9.
[38]Lee ST,Park JE,Lee K,et al.Noninvasive method of immortalized neural stem-like cell transplantation in an experimental model of Huntington's disease.J Neurosci Methods 2006 Apr 15;152(1-2):250-4.
[39]Lee ST,Chu K,Park JE,et al.Intravenous administration of human neural stem cells induces functional recovery in Huntington's disease rat model.Neurosci Res 2005 Jul;52(3):243-9.
[40]Roberts TJ,Price J,Williams SC,et al.Preservation of striatal tissue and behavioral function after neural stem cell transplantation in a rat model of Huntington's disease.Neuroscience 2006; 139(4):1187-99.
[41]Vazey EM,Chen K,Hughes SM,et al.Transplanted adult neural progenitor cells survive,differentiate and reduce motor function impairment in a rodent model of Huntington's disease.Exp Neurol.2006 Jun;199(2):384-96.
[42]Johann V,Schiefer J,Sass C,et al.Time of transplantation and cell preparation determine neural stem cell survival in a mouse model of Huntington's disease.Exp Brain Res.2007 Mar;177(4):458-70.
[43]Bachoud-Levi AC,Gaura V,Brugieres P,et al.Effect of fetal neural transplants in patients with Huntington's disease 6 years after surgery:a long term follow up study.Lancet Neurol.2006Apr;5(4):303-9.
[44]Aboody KS,Brown A,Rainov NG,et al.Neural stem cells display extensive tropism for pathology in adult brain:evidence from intracranial glioma.Proc Natl Acad Sci U S A.2000 Nov 7;97(23):12846-51.
[45]Zhang Z,Jiang Q,Jiang F,et al.In vivo magnetic resonance imaging tracks adult neural progenitor cell targeting of brain tumor.Neuroimage 2004 Sep;23(1):281-7.
[46]Tang Y,Shah K,Messedi SM,et al.In vivo tracking of neural progenitor cell migration to glioblastomas.Hum Gene Ther.2003 Sep 1;14(13):1247-54.
[47]Ehtesham M,Kabos P,Kabosova A,et al.The use of intedeukin 12-secreting neural stem cells for the treatment of intracranial glioma.Cancer Res.2002 Oct 15;62(20):5657-63.
[48]Ke Y,Chi L,Xu R,et al.Early response of endogenous adult neural progenitor cells to acute spinal cord injury in mice.Stem Cells 2006 Apr;24(4):1011-9.
[49]Li J,Sun CR,Zhang H,et al.Induction of functional recovery by co-transplantation of neural stem cells and Schwann ceils in a rat spinal cord contusion injury model.Biomed Environ Sci,2007 Jun;20(3):242-9.
[50]Guo JS,Zeng YS,Li HB,et al.Cotransplant of neural stem cells and NT-3 gene modified Schwann cells promote the recovery of transected spinal cord injury.Spinal Cord,2007 Jan;45(1):15-24.
[51]Lu P,Jones LL,Snyder EY,et al.Neural stem cells constitutively secrete neurotrophic factors and promote extensive host axonal growth after spinal cord injury.Exp Neurol 2003 Jun;181(2):115-29.
[52]Kamei N,Tanaka N,Oishi Y,et al.BDNF,NT-3,and NGF released from transplanted neural progenitor cells promote corticospinal axon growth in organo typic cocultures.Spine,2007 May 20;32(12):1272-8.
[53]Conti L,Reitano E,Cattaneo E.Neural stem cell systems:diversities and properties after transplantation in animal models of diseases.Brain Pathol.2006 Apr;16(2):143-54.
[54]Kerr DA,Llado J,Shamblott MJ,et al.Human embryonic germ cell derivatives facilitate motor recovery of rats with diffuse motor neuron injury.J Neurosei 2003 Jun 15;23(12):5131-40.
[55]Wu P,Tarasenko YI,Gu Y,et al.Region-specific generation of cholinergic neurons from fetal human neural stem cells grafted in adult rat.Nat Neurosci,2002 Dec;5(12):1271-8.
[56]Halfpenny CA,Scolding NJ.Immune-modifying agents do not impair the survival,migration or proliferation of oligodendrocyte progenitors(CG-4) in vitro.J.Neuroimmunol,2003 Jun;139(1-2):9-16.
[57]Br(u|¨)stle O,Jones KN,Learish RD,et al.Embryonic stem cell-derived glial precursors:a source of myelinating transplants.Science,1999 Jul 30;285(5428):754-6.
[58]Pluchino S,Quattrini A,Brambilla E,et al.Injection of adult neurospheres induces recovery in a chronic model of multiple sclerosis.Nature,2003 Apr 17;422(6933):688-94.
[59]Buchet D,Serguera C,Zennon V,et al.Long-term expression of beta-glucoronidase by genetically modefied human neural progenitor cells graned into the mouse central nervous system.Mol Cell Neurosci 2002,19(3):389-401.
[60]Kim HJ,Sugimori M,Nakafuku M,et al.Control of neurogenesis and tyrosine hydroxylase expression in neural progenitor cells through bHLH proteins and Nurrl.Exp Neurol.2007 Feb;203(2):394-405.
[61]Andersson EK,Irvin DK,Ahlsi(o|¨) J,et al.Ngn2 and Nurrl act in synergy to induce midbrain dopaminergic neurons from expanded neural stem and progenitor cells.Exp Cell Res.2007 Apr 1;313(6):1172-80.
[62]Kim SU.Genetically engineered human neural stem cells for brain repair in neurological diseases.Brain Dev.2007 May;29(4):193-201.
[63]Mezey E,Nagy A,Szalayova I,et al.Comment on "Failure of bone marrow cells to transdifferentiate into neural cells in vivo".Science 2003 Feb 21;299(5610):1184.
[64]Deng J,Petersen BE,Steindler DA,et al.Mesenchymal stem cells spontaneously express neural proteins in culture and are neurogenic after transplantation.Stem Cells 2006 Apr;24(4):1054-64.
[65]Zhao LR,Duan WM,Reyes M,et al.Human bone marrow stem cells exhibit neural phenotypes and ameliorate neurological deficits after grafting into the ischemic brain of rats.Exp Neurol,2002 Mar;174(1):11-20.
[66]Nishio Y,Koda M,Kamada T,et al.The use of hemopoietic stem cells derived from human umbilical cord blood to promote restoration of spinal cord tissue and recovery of hindlimb function in adult rats.J Neurosurg Spine,2006 Nov;5(5):424-33.
[67]Garbuzova-Davis S,Willing AE,Zigova T,et al.Intravenous administration of human umbilical cord blood cells in amouse model of amyotrophic lateral sclerosis:distribution,migration,and differentiation.J Hematother Stem Cell Res,2003 Jun;12(3):255-70.
[68]Dasari VR,Spomar DG,Gondi CS,et al.Axonal remyelination bycord blood stem cells after spinal cord injury.J Neurotrauma,2007 Feb;24(2):391-410.
包新明,舒斯云.大鼠脑立体定位图谱,北京:人民卫生出版社,1991,30-59.
陈生弟,陈先文.帕金森病动物模型的研制,中国神经免疫学和神经病学杂志.2003,10(1):28-32.
陈生弟,徐德隆.实验性帕金森病动物模型的研究,上海医学,1987,10:120-121.
李凌松,路艳艳.神经干细胞以及帕金森病的细胞治疗,北京大学学报(医学版),2002,34(5):499-505.
曾水林,王磊,朱建宝等.帕金森病大鼠黑质区神经干细胞分化的观察,解剖与临床,2007,12(1):27-30.
Akerud P,Canals JM,Snyder EY,et al.Neuroprotection through delivery of glial cell linederived neurotrophic factor by neural stem cells in a mouse model of Parkinson's disease.J Neurosci.2001 Oct 15;21(20):8108-18.
Alvarez-Buylla A,Temple S.Stem cells in the developing and adult nervous system.J Neurobiol.1998 Aug;36(2):105-10.
Alvarez-Buylla A,Garcia-Verdugo JM & Tramontin AD.A unified hypothesis on the lineage of neural stem cells.Nat.Rev.Neurosci.2001,2,287-93.
Ankovic J.Parkinson's disease therapy:tailoring choices for early and late,young and old patients.Clin Neuropharmacol,2000,23(5):252-61.
Beal MF.Experimental model of Parkinson's disease.Nature Rev Neurosci,2001,2:325-34.
Belmadani A,Tran PB,Ren D,et al.The chemokine stromal cell-derived factor-1 regulates the migration of sensory neuron progenitors,J Neurosci,2005,25(16):3995-4003.
Belmadani A,Tran PB,Ren D,et al.Chemokines regulate the migration of neural progenitors to sites of neuroinflammation,J Neurosci,2006,26(12):3182-91.
Beltrami AP,Barlucchi L,Torella D,et al.Adult cardiacstem cells are multipotent and support myocardial regeneration.Cell,2003,114(6):763-76.
Ben-Hur T,Idelson M,Khaner H,et al.Transplantation of human embryonic stem cell-derived neural progenitors improves behavioral deficitin Parkinsonian rats,Stem Cells.2004;22(7):1246-55.
Beresford JM,Davenport AP,Sirinathsinghji DJ,et al.Experimental hemiparkinsonism in the rat following chronic unilateral infusion of MPP+ into the nigrostriatal dopamine pathway-Ⅱdifferential localization of dopamine and cholecystokinin receptors.Neurosci,1988,27(1): 129-43.
Betarbet R,Sherer TB,MacKenzie G,et al.Chronic systemic pesticide exposure reproduces features of Parkinson's disease.Nat Neurosci,2000,3:1301-06.
Blum D,Torch S,Lambeng N,et al.Molecular pathway involved in the neurotoxicity of 6-OHDA,dopamine and MPTP:contribution to the apoptotic theory in Parkinson s disease.Prog Neurobiol.2001 Oct;65(2):135-72.
Bj(o|¨)rklund A,Lindvall O.Cell replacement therapies for central nervous system disorders.Nat Neurosci.2000 Jun;3(6):537-44.
Bjugstad KB,Teng YD,Redmond DE Jr,et al.Human neural stem cells migrate along the nigrostriatal pathway in a primate model of Parkinson's disease.Exp Neurol.2008 Jun;211(2):362-9.
Brazel CY,Romanko MJ,Rothstein RP,et al.Roles of the mammalian subventricular zone in brain development.Prog Neurobiol.2003 Jan;69(1):49-69.
Brededau A,Correia AS,Anisimov SV,et al.Transplantation of human embryonic stem cellderived cells to a rat model of Parkinson's disease:effect of in vitro differentiation on graft survival and teratoma formation.Stem Cells.2006 Jun;24(6):1433-40.
Bronte-Stewart H.Parkinson's disease:Surgical options.Curr Treat Options Neurol,2003,5(2):131-47.
Brundin P,Isacson O,Bj(o|¨)rklund A.Monitoring of cell viability in suspensions of embryonic CNS tissue and its use as a criterion for intracerebral graft survival.Brain Res.1985 Apr 8;331(2):251-9.
Brundin P,Isacson O,Gage FH,et al.The 6-hydroxydopamine-lesioned mouse as a model for assessing functional effects of neuronal grafting.Brain Res.1986 Feb 26;366(1-2):346-9.
Chehab FF,Mounzih K,Lu R,et al.Early onset of reproductive function in normal female mice treated with leptin.Science,1997,275(5296):88-90.
Chmielnicki E,Benraiss A,Economides AN,et al.Adenovirally expressed noggin and brainderived neurotrophic factor cooperate to induce new medium spiny neurons from resident progenitor cells in the adult striatal ventricular zone.J Neurosci,2004,24(9):2133-42.
Cormack BP,Valdivia RH,Falkow S.FACS-optimized mutants of the green fluorescent protein (GFP).Gene,1996,173:33-8.
Cowan CA,Klimanskaya I,McMahon J,et al.Derivation of embryonic tem-cell lines from human blastocysts.N Engl J Med,2004,350:1353-56.
Cummings BJ,Uchida N,Tamaki SJ,et al.Human neural stem cells differentiate and promote locomotor recovery inspinal cord-injured mice.Proc Nail Acad Sci U S A.2005 Sep 27;102(39):14069-74.
Ding S,Messam CA,Li P,et al.Murine brain progenitor cells have the ability to differentiate into functional neurons and integrate into the CNS,Cell Transplant.,2006,15(8-9):699-710.
During MJ.Adeno-associated Virus as a gene delivery System.Adv Drug Deliv Rev.1997 Aug 11;27(1):83-94.
Dwain I,Xiangpeng Y,Zeng Z,et al.Neural stem cells-a promising potential therapy for brain tumors,Curr Stem Cell Res Ther.,2006,1(1):79-84.
Espino A,Liorens J,Calopa M,et al.Cerebrospinal dopamine metabolites in rats after intrastriatal administration of 6-hydroxydopamine or 1-methyl-4-phenylpyridinium ion.Brain Res.1995 Jan 9;669(1):19-25.
Feany MB,Bender WW.A drosophila model of Parkinson's disease.Nature,2000;404(6776):394-8.
Fillmore HL,Holloway KL,Gillies GT.Cell replacement efforts to repair neuronal injury:a potential paradigm for the treatment of Parkinson's disease.Review Neuro Rehabilitation,2005,20(3):233-42.
Gage FH,Ray J,Fisher LJ.Isolation,characterization,and use of stem cells from the CNS.Annu Rev Neurosci.1995;18:159-92.
Gage FH.Mammalian neural stem cells.Science.2000 Feb 25;287(5457):1433-8
Giasson BI,Duda JE,Quinn SM,et al.Neuronal alpha-synucleinopathy with severe movement disorder in mice expressing A53T human alphasynuclein.Neuron,2002;34(4):521-33.
Goldman SA,Roy NS,Beal MF,et al.Large stem cell grafts could lead to erroneous interpretations of behavioral results ? Nat Med.2007 Feb;13(2):118-9.
Hauser RA,Freeman TB,Snow BJ,et al.Long-term evaluation of bilateral fetal nigral transplantation in Parkinson's disease.Arch Neurol.1999 Feb;56(2):179-87.
Heim R,Cubitt AB,Heim RA,et al.Improved green fluorescence.Nature,1995,373(6516):663- 64.
Hellmann MA,Panet H,Barhum Y,et al.Increased survival and migration of engrafted mesenchymal bone marrow stem cells in 6-hydroxydopamine-lesioned rodents.Neurosci Lett. 2006 Mar 6;395(2):124-8.
Hockfield S,McKay RD.Identification of major cell classes in the developing mammalian nervous system.J.Neurosci.1985 Dec;5(12):3310-28.
Hori J,Ng TF,Shatos M,et al.Neural progenitor cells lack immuno-genicity and resist destruction as allografts.Stem Cells,2003,21(4):405-16.
Hudson JL,Levin DR,Hoffer BJ.A 16-channel automated romometer system for reliable measurement of turning behavior in 6-hydroxydopamine lesioned and transplanted rats.Cell Transplant.1993 Nov-Dec;2(6):507-14.
Hudson JL,Van Horne CG,Stromberg I,et al.Correlation of apomorphine and amphetamineinduced turning with nigrostfiatal dopamine content in unilateral 6-hydroxydopamine lesioned rats.Brain Res,1993,626:167-74.
Imitola J,Raddassi K,Park KI,et al.Directed migration of neural stem cells to sites of CNS injury by the stromal cell-derived factor lalpha/CXC chemokine receptor 4 pathway,Proc Natl Acad Sci U S A.2004 Dec 28;101(52):18117-22.
Isacson O,Costantini L,Schumacher JM,et al.Cell implantation therapies for Parkinson's disease using neural stem,transgenic or xengeneicdonor cells,Parkinsonism Relat Disord.2001Jul;7(3):205-12.
Iwanami A,Kaneko S,Nakamura M,et al.Transplantation of human neural stem cells for spinal cord injury in primates.J Neurosci Res.2005 Apr 15;80(2):182-90.
Jain M,Armstrong RJ,Elneil S,et al.Transplanted human neural precursor cells migrate widely but show no lesion-specific tropism in the 6-hydroxydopamine rat model of Parkinson's disease,Cell Transplant.,2006,15(7):579-93.
Jenner P.Pharmacology of dopamine agonists in the treatment of Parkinson's disease.Neurology 2002 Feb 26;58(4 Suppl 1):S1-8.
Ji JF,He BP,Dheen ST,et al.Expression of chemokine receptors CXCR4,CCR2,CCR5 and CX3CR1 in neural progenitor cells isolated from the subventricular zone of the adult rat brain,Neurosci Lett,2004 Jan 30;355(3):236-40.
Johe KK,Hazel TG,Muller T et al.Single factors direct the differentiation of stem cells from the fetal and adult central nervous system.Genes Dev.1996 Dec 15;10(24):3129-40.
Kawaguchi A,Miyata T,Sawamoto K,et al.Nestin-EGFP transgenie mice:visualization of the self-renewal and multipotency of CNS stem cells.Mol Cell Neurosci 2001 Feb,17(2):259-73.
Kelly S,Bliss TM,Shah AK,et al.Transplanted human fetal neural stem cells survive,migrate,and differentiate in ischemic rat cerebral cortex.Proc Natl Acad Sci U S A.2004 Aug 10;101(32):11839-44.
Kempermann G.Adult neurogenesis.2006,New York,NY:Oxford University Press.
Keyoung HM,Roy NS,Benraiss A,et al.High-yield selection and extraction of two promoterdefined phenotypes of neural stem cells from the fetal human brain.Nat Biotechnol.2001 Sep;19(9):843-50.
Kim JH,Auerbach JM,Rodriguez-Gomez JA,et al.Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson's disease,Nature.2002 Jul 4;418(6893):50-6.
Kim JY,Koh HC,Lee JY,et al.Dopaminergic neuronal differentiation from rat embryonic neural precursors by Nurrl overexpression.J Neurochem.2003 Jun;85(6):1443-54.
Lendahl U,Zimmerman LB,McKay RD.CNS stem cells express a new class of intermediate filament protein.Cell,1990,60,585-95.
Lindvall O,Kokaia Z,Martinez-Serrano A.Stem cell therapy for human neurodegenerative disorders-how to make it work.Nat Med.2004 Jul;10 Suppl:S42-50.
Lotharius J,Brundin P.Pathogenesis of Parkinson's disease:dopamine,vesicles and alphasynuclein.Nat Rev Neurosci.2002 Dec;3(12):932-42.
Lu M,Grove EA,Miller RJ.Abnormal development of the hippocampal dentate gyrus in mice lacking the CXCR4 chemokine receptor,Proc Natl Acad Sci USA,2002 May 14;99(10):7090-5.
Lundberg C,Martinez-Serrano A,Cattaneo E,et al.Survival,integration,and differentiation of neural stem cell lines after transplantation to the adult rat striatum.Exp Neurol.1997 Jun;145(2Pt 1):342-60.
Maitra A,Arking DE,Shivapurkar N,et al.Genomic alterations in cultured human embryonic stem cells.Nat Genet,2005 Oct;37(10):1099-103.
McBride JL,Behrstock SP,Chen EY,et al.Human neural stem cell transplants improve motor function in a rat model of Huntington's disease.J Comp Neurol.2004 Jul 19;475(2):211-9.
McCown TJ,Xiao X,Li J,et al.Differential and persistent expression patterns of CNS gene transfer by an adeno-associated virus(AAV) vector.Brain Res.1996 Mar 25;713(1-2):99-107.
McDonald JW,Liu XZ,Qu Y,et al.Transplanted embryonic stem cells survive,differentiate and promote recovery in injured rat spinal cord.Nat Med.1999 Dec;5(12):1410-2.
Mckay R.Stem cells in the central neurons system.Science,1997,276,66-71.
Meissner KK,Kirkham DL,Doering LC.Transplants of neurosphere cell suspensions from aged mice are functional in the mouse model of Parkinson's,Brain Res.2005 Sep 28;1057(1-2):105-12.
Menendez P,Bueno C,Wang L.Human embryonic stem cells:a journey beyond cell replacement therapies.Cytotherapy 2006;8(6):530-41.
Mogi M,Nagatsu T.Neurotrophins and cytokines in Parkinson's disease.Adv Neurol 1999;80:135-9.
Morizane A,Li JY,Brundin P.From bench to bed:the potential of stem cells for the treatment of Parkinson's disease.Cell Tissue Res.2008 Jan;331(1):323-36.
Mukhida K,Baghbaderani BA,Hong M,et al.Survival,differentiation,and migration of bioreactor-expanded human neural precursor cells in a model of Parkinson disease in rats,Neurosurg Focus,2008,24(3-4):E8.
M(u|¨)ller FJ,Snyder EY,Loring JF.Gene therapy:can neural stem cells deliver? Nat Rev Neurosci.2006 Jan;7(1):75-84.
Nakamura S,Takeda Y,Kanno M,et al.Application of bromodeoxyuridine(BrdU) and anti-BrdU monoclonal anti-body for the in vivo analysis of proliferative characteristics of human leukemia cells in bone marrow.Oncology,1991,48(4):285-9.
Newman MB,Bakay RA.Therapeutic Potentials of Human Embryonic Stem Cells in Parkinson's Disease.Neurotherapeutics 2008 Apr;5(2):237-51.
Nishino H,Hida H,Takei N,et al.Mesencephalic neural stem cells develop to dopamlmeergic neuronsmore strongly in dopamine- depleted striatum than in intact striatum.Exp Neurol,2000,164(1):209-14.
Nunes MC,Roy NS,Keyoung HM,et al.Identification and isolation of multipotential neural progenitor cells from the subcortical white matter of the adult human brain,Nat Med.2003 Apr;9(4):439-47.
Okano H,Kawahara H,Toriya M,et al.Function of RNA binding protein Musashi-1 in stem cells.Exp.Exp Cell Res.2005 Jun 10;306(2):349-56.
Okano H.Neuralstem cells:progression of basic research and perspective for clinical application.Keio J Med.2002 Sep;51(3):115-28.
Okano H,Sawamoto K.Neural stem cells:involvement in adult neurogenesis and CNS repair.Philos Trans R Soc Lond B Biol Sci.2008 Jun 27;363(1500):2111-22.
Okano H.Stem cell biology of the central nervous system,J Neurosci Res.2002 Sep 15;69(6):698-707.
Pahwa R,Factor SA,Lyons KE,et al.Practice parameter:treatment of Parkinson disease with motor fluctuations and dyskinesia(anevidence-basedreview):report of the Quality Standards Subcommittee of the American Academy of Neurology.Neurology,2006 Apr 11;66(7):983-95.
Park KI,Hack MA,Ourednik J,et al.Acute injury directs the migration,proliferation,and differentiation of solid organ stem cells:evidence from the effect of hypoxia-ischemia in the CNS on clonal "reporter" neural stem cells.Exp Neurol.2006 May;199(1):156-78.
Park KI,Liu S,Flax JD,et al.Transplantation of neural progenitor and stem-like cells:developmental insights may suggest new therapies for spinal cord and other CNS dysfunction.J.Neurotraumal,1999,6:675-687.
Paterna JC,B(u|¨)eler H.Recombinant adeno-associated virus vector design and gene expression in the mammalian brain.Methods.2002 Oct;28(2):208-18.
Pendleton RG,Parvez F,Sayed M,et al.Effects of pharmacological agents upon a transgenic model of Parkinson's disease in Drosophila melanogaster.J Pharmacol Exp Ther,2002 Jan;300(1):91-6.
Perlow MJ,Freed WJ,Hoffer BJ,et al.Brain grafts reduce motor abnormalities produced by destruction of nigrostriatal dopamine system.Science.1979 May 11;204(4393):643-7
Pevny LH,Sockanathan S,Placzek M et al.A role for SOX1 in neural determination.Development,1998 May;125(10),1967-78.
Prasher DC,Eckenrode VK,Ward WW,et al.Primary structure of theaequorea Victoria greenfluorescent protein.Gene,1992,111(2):229-33.
Reynolds BA,Tetzlaff W,Weiss S.A multipotent EGF-responsive striated embryonic progenitor cell produces neurons and astrocytes.J.Neurosci 1992 Nov,12(11),4565-74.
Reynolds BA,Weiss S.Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system.Science,1992 Mar 27;255(5052):1707-10.
Ramony Cajal S.1928 Degeneration and regeneration of the Nervous system.Oxford,UK:Oxford University Press.[Transl.by R.M.Day from the 1913 Spanish edn.]
Rietze RL,Valcanis H,Brooker GF,et al.Purification of a pluripotent neural stem cell from the adult mouse brain.Nature 2001 Aug 16;412(6848):736-9.
Ronald Mckay.Stem cells in the central neurous system.Science 1997 Apr 4;276(5309):66-71.
Sakakibara S,Imal T,Hamaguchi K,et al.Mouse-Musashi-1,a neural RNA-binding protein highly enriched in the mammalian CNS stemcell.Dev Biol.1996 Jun 15;176(2):230-42.
Samii A,Nutt JG,Ransom BR.Parkinson's disease.Lancet,2004 May 29,363(9423):1783-93.
Sipkis IG.A possible mechanism for the dopamine evoked synergistic disinhition of thalamic neurons via the direct and indirect pathways in the basal ganglin,Neurosie Behaiphysiol,2002,32(3):205.
Svendsen CN,Caldwell MA,Ostenfeld T.Human neural stem cells:isolation,expansion and transplantation,Brain Pathol.1999 Jul;9(3):499-513.
Takeuchi H,Natsume A,Wakabayashi T,et al.Intravenously transplanted human neural stem cells migrate to the injured spinal cord in adult mice in an SDF-1- and HGF-dependent manner,Neurosci Lett.,2007,426(2):69-74
Tan AK.Current and emerging treatment in Parkinson's disease.Ann Acad Med(singapore),2001,30(2):128-133.
Tang J,Xu HW,Fan XT,et al.Targeted migration and differentiation of engrafted neural precursor cells in amyloid beta-treated hippocampus in rats.Neurosci Bull 2007 Sep;23(5):263-70.
Tanja Z,V Pencea,R Betarbet,et al.Neuronal progenitor cells of the neonatal subventricular zone differentiate and disperse following transplantation into the adult rat striatum,Cell Transplantation,1998,7(2):137-156.
Thiruchelvam M,Richfield EK,Baggs RB,et al.The nigrostriatal dopaminergic system as a preferential target of repeated exposures to combined paraquat and maneb:implications for Parkinson's disease.J Neurosci,2000 Dec 15,20(24):9207-14.
Timmer M,Grosskreutz J,Schlesinger F,et al.Dopaminergic properties and function after grafting of attached neural precursor cultures.Neurobiol Dis.2006 Mar;21(3):587-606.
Tran PB,Ren D,Veldhouse TJ,et al.Chemokine receptors are expressed widely by embryonic and adult neural progenitor cells,J Neurosci Res 2004 Apr 1;76(1):20-34.
Turner DA,Kearney W.Scientific and ethical concerns in neural fetal Tissue transplantation,Neurosurgery 1993 Dec;33(6):1031-7.
Uchida N,Buck DW,He D,et al.Direct isolation of human central nervous system stem cells.Proc Natl Acad Sci U S A.2000 Dec 19;97(26):14720-5.
Ungerstedt D.6-hydroxydopamine induced degeneration of central monoamine neurons.Eur J Pharmocol,1988,5:107.
Vander Kooy D,Weiss S.Why stem cells? Science.2000 Feb 25;287(5457):1439-41.
Van Kampen JM,McGeer EG.Stoessl AJ.Dopamine transporter function assessed by antisense knockdown in the rat:protection from dopamine neurotoxicity.Synapse.2000 Sep 1;37(3):171-8.
Wang X,Lu Y,Zhang H,et al.Distinct efficacy of pre-differentiated versus intact fetal mesencephalon-derived human neural progenitor cells in alleviating rat model of Parkinson's disease.Int.J.Dev.Neurosci.2004 Jun,22(4):175-83.
Weiss S,Reynolds BA,Vescovi AL,et al.Is there a neural stem cell in the mammalian forebrain?TINS,1996,19(9):387-93.
Whitton PS.Inflammation as a causativefactor in theaetiology of Parkinson's disease.Br J Pharmacol 2007;150:963-76.
Wood HB,Episkopou V.Comparative expression of the mouse Sox1,Sox2 and Sox3 genes from pregastrulation to early somite stages.Mech Dev.1999 Aug;86(1-2):197-201.
Yasuhara T,Matsukawa N,Hara K,Yu G,Xu L,Maki M,Kim SU,Borlongan CV.Transplantation of human neural stem cells exerts neuroprotection in a rat model of Parkinson's disease.J Neurosci.2006 Nov 29;26(48):12497-511.
Zetterstroem T,Brundin P,Gage FH,et al.In vivo measurement of spontaneous release and metabolism of dopamine from intrastriatal nigral grafts using intracerebral dialysis.Brain Res.1986 Jan 8;362(2):344-9.
Zhang RL,Zhang L,Zhang ZG,et al.Migration and differentiation of adult rat subventricular zone progenitor cells transplanted into the adult rat striatum,Neuroscience.2003;116(2):373-82.
Zhou C,Wen ZX,Wang ZP,et al.Green fluorescent protein-labeled mapping of neural stem cells migrating towards damaged areas in the adult central nervous system.Cell Biol Int.2003;27(11):943-5.